Does cannabis use cause heart disease? The evidence is mixed, but cardiologists urge caution
#62 Notable Clinical Interest
Emerging findings or policy developments worth monitoring closely.
Clinicians need to understand the cardiovascular risks of cannabis, particularly arrhythmias, to properly counsel patients—especially older adults—about potential cardiac complications before recommending or approving use. The mixed evidence base makes it difficult to establish firm clinical guidelines, requiring providers to engage in individualized risk-benefit discussions with patients who use or are considering cannabis. Given increasing cannabis legalization and use among older populations with existing cardiac disease, cardiologists and primary care providers should routinely assess cannabis use during cardiovascular evaluations and adjust monitoring accordingly.
Cannabis use in older adults appears associated with increased risk of atrial and ventricular arrhythmias, yet the current evidence base remains inconsistent, with studies showing conflicting results regarding cannabis’s direct contribution to heart disease development. Cardiologists recommend a cautious approach given the potential for serious cardiac complications, particularly arrhythmias, though establishing definitive causation has proven challenging due to confounding factors, variable study designs, and the difficulty isolating cannabis use from other cardiovascular risk factors in observational data. The mechanistic pathways linking cannabis to cardiac toxicity involve both sympathomimetic effects and inflammatory responses, but long-term prospective studies specifically designed to clarify these mechanisms in controlled populations remain limited. For clinicians managing older patients or those with existing cardiac disease, obtaining a detailed cannabis use history and counseling patients about potential arrhythmia risks represents prudent clinical practice even as the field awaits higher-quality evidence. Patients considering cannabis use for medical conditions should discuss their cardiovascular risk profile with their cardiologist before initiation, particularly those with known arrhythmia history or multiple cardiac risk factors.
“The observational data linking cannabis to arrhythmia risk in older adults raises legitimate clinical concern, but we’re still working to separate causation from correlation in this population. Until we have prospective, controlled human studies, my approach is to counsel patients candidly about what we don’t yet know while taking their individual cardiac history seriously.”
🫀 While cannabis use has shown associations with arrhythmias in observational studies, the evidence base remains limited by confounding variables, reporting bias, and the difficulty of establishing causation in retrospective analyses. Older adults using cannabis may have underlying cardiovascular risk factors, concurrent substance use, or medication interactions that are not fully captured in existing literature, complicating efforts to isolate cannabis as an independent cardiac risk factor. Nevertheless, the plausible mechanisms by which cannabinoids affect heart rate variability, autonomic tone, and arrhythmia susceptibility warrant clinical attention, particularly given the growing prevalence of cannabis use in aging populations. Clinicians should include cannabis use in cardiovascular risk assessments, especially when evaluating new-onset arrhythmias or unexplained palpitations in older patients, while acknowledging that definitive causality has not yet been established and discussing both the uncertainty and the potential risks with patients who
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
